Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266721 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Pancrelipase on Postprandial Belching and Bloating.
A Phase 3 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT00266721: Completed Phase 3 study, sponsored by Solvay Pharmaceuticals.
NCT00266721 is a Phase 3 study that has completed, run by Solvay Pharmaceuticals. The registered enrollment target is 45 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266721, a Phase 3 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.
Interventions
- DRUG Pancrelipase (Creon) 2 tablets with each meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2000-01 |
| Est. Completion | 2000-10 |
| Phase | Phase 3 |
What the finished NCT00266721 record still lists
NCT00266721 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Pancrelipase (Creon) 2 tablets with each meal is the first listed.
NCT00266721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266721 about?
NCT00266721 is a clinical study titled "Efficacy of Pancrelipase on Postprandial Belching and Bloating.". The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.
What is the current status of trial NCT00266721?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2000-01. Estimated completion is 2000-10.
What interventions are being tested in trial NCT00266721?
The interventions under investigation include: Pancrelipase (Creon) 2 tablets with each meal (DRUG).
Who is sponsoring clinical trial NCT00266721?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00266721's enrollment target sits among peer trials
45 1870th of 2000 higher than 127 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia